Literature DB >> 21651344

Endothelin-1 attenuates the hemodynamic response to exogenous epinephrine in a porcine ischemic ventricular fibrillation cardiac arrest model.

Atman P Shah1, Scott T Youngquist, Christian D McClung, Joseph L Thomas, Ekaterina Tzvetkova, Mohammed A Hanif, John P Rosborough, James T Niemann.   

Abstract

Endothelin-1 (ET-1) increases in the ischemically induced ventricular fibrillation (VF) swine model of cardiac arrest and affects outcome by potentially attenuating the hemodynamic response to epinephrine. Fifty-one swine underwent percutaneous left anterior descending occlusion. Seven minutes postonset of ischemic VF, cardiopulmonary resuscitation (CPR) was initiated. If VF persisted after 3 shocks, 1 mg of epinephrine was given. ET-1 (collected at baseline and every 5 min until VF onset) was assayed with ELISA. Bayesian multivariate logistic regression analysis compared peak ET-1 levels with the binary outcome of a positive coronary perfusion pressure response of >20 mmHg following epinephrine. Sixteen animals (31%) failed to achieve a positive response. Restoration of spontaneous circulation (ROSC) was observed in 1/16 (6.3%) of epinephrine nonresponders and 20/35 (57.1%) of epinephrine responders (P = 0.0006). The median peak ET-1 level was 2.71 pg/mL [interquartile range (IQR) 1.06-4.40] in nonresponders and 1.69 pg/mL (IQR 0.99-2.35) in responders. ET-1 levels were inversely associated with epinephrine response with a median posterior odds ratio (OR) of a coronary perfusion pressure response of 0.72 (95% confidence interval [CI] 0.48-1.06) for each one-unit increase in ET-1 and a probability that the associated OR is <1 of 0.95. Peak ET-1 levels predict a lack of a hemodynamic response to epinephrine during treatment of cardiac arrest during ischemic VF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21651344      PMCID: PMC3173818          DOI: 10.1089/jir.2011.0012

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  25 in total

Review 1.  Role of endothelins in septic, cardiogenic, and hemorrhagic shock.

Authors:  S Magder; P Cernacek
Journal:  Can J Physiol Pharmacol       Date:  2003-06       Impact factor: 2.273

2.  2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors: 
Journal:  Circulation       Date:  2005-11-28       Impact factor: 29.690

3.  Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council.

Authors:  Robert W Neumar; Jerry P Nolan; Christophe Adrie; Mayuki Aibiki; Robert A Berg; Bernd W Böttiger; Clifton Callaway; Robert S B Clark; Romergryko G Geocadin; Edward C Jauch; Karl B Kern; Ivan Laurent; W T Longstreth; Raina M Merchant; Peter Morley; Laurie J Morrison; Vinay Nadkarni; Mary Ann Peberdy; Emanuel P Rivers; Antonio Rodriguez-Nunez; Frank W Sellke; Christian Spaulding; Kjetil Sunde; Terry Vanden Hoek
Journal:  Circulation       Date:  2008-10-23       Impact factor: 29.690

4.  Release of endogenous vasopressors during and after cardiopulmonary resuscitation.

Authors:  K H Lindner; T Haak; A Keller; U Bothner; K G Lurie
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

5.  Effects of endothelin-1 on resuscitation rate during cardiac arrest.

Authors:  D J DeBehnke; L Benson
Journal:  Resuscitation       Date:  2000-10       Impact factor: 5.262

6.  Clinical significance of acute-phase endothelin-1 in acute myocardial infarction patients treated with direct coronary angioplasty.

Authors:  Toshiro Katayama; Katsusuke Yano; Hiroshi Nakashima; Chisa Takagi; Yukiharu Honda; Shin Suzuki; Yoshihiro Iwasaki
Journal:  Circ J       Date:  2005-06       Impact factor: 2.993

7.  Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial.

Authors:  Theresa M Olasveengen; Kjetil Sunde; Cathrine Brunborg; Jon Thowsen; Petter A Steen; Lars Wik
Journal:  JAMA       Date:  2009-11-25       Impact factor: 56.272

8.  Reduced vascular response to phenylephrine during exposure to lipopolysaccharide in vitro involves nitric oxide and endothelin 1.

Authors:  Johann K Scicluna; Arnaud Mansart; Jonathan J Ross; Charles S Reilly; Nicola J Brown; Zoë L S Brookes
Journal:  Shock       Date:  2008-03       Impact factor: 3.454

9.  Regional systems of care for out-of-hospital cardiac arrest: A policy statement from the American Heart Association.

Authors:  Graham Nichol; Tom P Aufderheide; Brian Eigel; Robert W Neumar; Keith G Lurie; Vincent J Bufalino; Clifton W Callaway; Venugopal Menon; Robert R Bass; Benjamin S Abella; Michael Sayre; Cynthia M Dougherty; Edward M Racht; Monica E Kleinman; Robert E O'Connor; John P Reilly; Eric W Ossmann; Eric Peterson
Journal:  Circulation       Date:  2010-01-14       Impact factor: 29.690

10.  Survival outcomes with the introduction of intravenous epinephrine in the management of out-of-hospital cardiac arrest.

Authors:  Marcus Eng Hock Ong; Eng Hoe Tan; Faith Suan Peng Ng; Anushia Panchalingham; Swee Han Lim; Peter George Manning; Victor Yeok Kein Ong; Steven Hoon Chin Lim; Susan Yap; Lai Peng Tham; Kheng Siang Ng; Anantharaman Venkataraman
Journal:  Ann Emerg Med       Date:  2007-05-23       Impact factor: 5.721

View more
  1 in total

1.  Plasma big endothelin-1 is an effective predictor for ventricular arrythmias and end-stage events in primary prevention implantable cardioverter- defibrillator indication patients.

Authors:  Xiao-Yao Li; Shuang Zhao; Xiao-Han Fan; Ke-Ping Chen; Wei Hua; Zhi-Min Liu; Xiao-Di Xue; Bin Zhou; Shu Zhang
Journal:  J Geriatr Cardiol       Date:  2020-07-28       Impact factor: 3.327

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.